Induction of NRF2-mediated gene expression by dietary phytochemical flavones apigenin and luteolin

Biopharmaceutics and Drug Disposition

Volumn 36, Issue 7, 2015, Pages 440-451

  Paredes Gonzalez, Ximena ^a   Fuentes, Francisco ^b   Jeffery, Sundrina ^a   Saw, Constance Lay Lay ^a   Shu, Limin ^a   Su, Zheng Yuan ^c   Kong, Ah Ng Tony ^a  

^a RUTGERS UNIVERSITY   (United States)

^b PONTIFICIA UNIVERSIDAD CATÓLICA DE CHILE   (Chile)

^c CHUNG YUAN CHRISTIAN UNIVERSITY   (Taiwan)

Author keywords

apigenin; HepG2; LPS; luteolin; Nrf2

Indexed keywords

2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; 2 MORPHOLINO 8 PHENYLCHROMONE; APIGENIN; CYTOSOLIC PHOSPHOLIPASE A2; HEME OXYGENASE 1; INDUCIBLE NITRIC OXIDE SYNTHASE; LIPOPOLYSACCHARIDE; LUTEOLIN; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE; NITRIC OXIDE; PHOSPHATIDYLINOSITOL 3 KINASE; SULFORAPHANE; TRANSCRIPTION FACTOR NRF2; FLAVONE DERIVATIVE; NFE2L2 PROTEIN, HUMAN; PLANT MEDICINAL PRODUCT;

ANTIINFLAMMATORY ACTIVITY; ANTIOXIDANT RESPONSIVE ELEMENT; ARTICLE; CELL VIABILITY; CONTROLLED STUDY; GENE EXPRESSION; HEPG2 CELL LINE; HUMAN; HUMAN CELL; PROTEIN INDUCTION; SIGNAL TRANSDUCTION; TRADITIONAL MEDICINE; AGONISTS; BIOSYNTHESIS; CELL SURVIVAL; DOSE RESPONSE; DRUG EFFECTS; GENE EXPRESSION REGULATION; GENETICS; PHYSIOLOGY;

APIGENIN; CELL SURVIVAL; DOSE-RESPONSE RELATIONSHIP, DRUG; FLAVONES; GENE EXPRESSION REGULATION; HEP G2 CELLS; HUMANS; LUTEOLIN; NF-E2-RELATED FACTOR 2; PHYTOCHEMICALS;

EID: 84945181944     PISSN: 01422782     EISSN: 1099081X     Source Type: Journal    
DOI: 10.1002/bdd.1956     Document Type: Article

References (50)

1. Lee JH, Khor TO, Shu L, Su ZY, Fuentes F, Kong AN,. Dietary phytochemicals and cancer prevention: Nrf2 signaling, epigenetics, and cell death mechanisms in blocking cancer initiation and progression. Pharmacol Ther 2013; 137 (2): 153-171.
2. Sak K,. Cytotoxicity of dietary flavonoids on different human cancer types. Pharmacogn Rev 2014; 8 (16): 122-146.
3. Chen T, Li LP, Lu XY, Jiang HD, Zeng S,. Absorption and excretion of luteolin and apigenin in rats after oral administration of Chrysanthemum morifolium extract. J Agric Food Chem 2007; 55 (2): 273-277.
4. Benavente-Garcia O, Castillo J,. Update on uses and properties of citrus flavonoids: new findings in anticancer, cardiovascular, and anti-inflammatory activity. J Agric Food Chem 2008; 56 (15): 6185-6205.
5. Graf BA, Milbury PE, Blumberg JB,. Flavonols, flavones, flavanones, and human health: epidemiological evidence. J Med Food 2005; 8 (3): 281-290.
6. Birt DF, Hendrich S, Wang W,. Dietary agents in cancer prevention: flavonoids and isoflavonoids. Pharmacol Ther 2001; 90 (2-3): 157-177.
7. Lin Y, Shi R, Wang X, Shen HM,. Luteolin, a flavonoid with potential for cancer prevention and therapy. Curr Cancer Drug Targets 2008; 8 (7): 634-646.
8. Shukla S, Gupta S,. Apigenin: a promising molecule for cancer prevention. Pharm Res 2010; 27 (6): 962-978.
9. Valdameri G, Trombetta-Lima M, Worfel PR, et al., Involvement of catalase in the apoptotic mechanism induced by apigenin in HepG2 human hepatoma cells. Chem Biol Interact 2011; 193 (2): 180-189.
10. Hwang J-T, Park OJ, Lee YK, et al., Anti-tumor effect of luteolin is accompanied by AMP-activated protein kinase and nuclear factor-kappaB modulation in HepG2 hepatocarcinoma cells. Int J Mol Med 2011; 28 (1): 25-31.
11. Hanahan D, Weinberg RA,. Hallmarks of cancer: the next generation. Cell 2011; 144 (5): 646-674.
12. Saw CL, Cintron M, Wu TY, et al.,. Pharmacodynamics of dietary phytochemical indoles I3C and DIM: induction of Nrf2-mediated phase II drug metabolizing and antioxidant genes and synergism with isothiocyanates. Biopharm Drug Dispos 2011; 32 (5): 289-300.
13. Byun S, Park J, Lee E, et al., Src kinase is a direct target of apigenin against UVB-induced skin inflammation. Carcinogenesis 2013; 34 (2): 397-405.
14. Su ZY, Shu L, Khor TO, Lee JH, Fuentes F, Kong AN,. A perspective on dietary phytochemicals and cancer chemoprevention: oxidative stress, Nrf2, and epigenomics. Top Curr Chem 2013; 329: 133-162.
15. Huang C-S, Lii CK, Lin AK, et al., Protection by chrysin, apigenin, and luteolin against oxidative stress is mediated by the Nrf2-dependent up-regulation of heme oxygenase 1 and glutamate cysteine ligase in rat primary hepatocytes. Arch Toxicol 2013; 87 (1): 167-178.
16. Paredes-Gonzalez X, Fuentes F, Su ZY, Kong AN,. Apigenin reactivates Nrf2 anti-oxidative stress signaling in mouse skin epidermal JB6 P+ cells through epigenetics modifications. AAPS J 2014; 16 (4): 727-735.
17. Liu G-H, Qu J, Shen X,. NF-kappaB/p65 antagonizes Nrf2-ARE pathway by depriving CBP from Nrf2 and facilitating recruitment of HDAC3 to MafK. Biochim Biophys Acta 2008; 1783 (5): 713-727.
18. Kehrer JP,. Free radicals as mediators of tissue injury and disease. Crit Rev Toxicol 1993; 23 (1): 21-48.
19. Cardozo LFMF, Pedruzzi LM, Stenvinkel P, et al., Nutritional strategies to modulate inflammation and oxidative stress pathways via activation of the master antioxidant switch Nrf2. Biochimie 2013; 95 (8): 1525-1533.
20. Cheung KL, Lee JH, Khor TO, et al., Nrf2 knockout enhances intestinal tumorigenesis in Apc(min/+) mice due to attenuation of anti-oxidative stress pathway while potentiates inflammation. Mol Carcinog 2012; 53 (1): 77-84.
21. Hwang Y-J, Lee EW, Song J, Kim HR, Jun YC, Hwang KA,. MafK positively regulates NF-kappaB activity by enhancing CBP-mediated p65 acetylation. Sci Rep 2013; 3: 3242.
22. Saw CL, Huang MT, Liu Y, Khor TO, Conney AH, Kong AN,. Impact of Nrf2 on UVB-induced skin inflammation/photoprotection and photoprotective effect of sulforaphane. Mol Carcinog 2011; 50 (6): 479-486.
23. Saw CLL, Yang AY, Huang MT, et al., Nrf2 null enhances UVB-induced skin inflammation and extracellular matrix damages. Cell Biosci 2014; 4: 39.
24. Nicholas C, Batra S, Vargo MA, et al., Apigenin blocks lipopolysaccharide-induced lethality in vivo and proinflammatory cytokines expression by inactivating NF-kappaB through the suppression of p65 phosphorylation. J Immunol 2007; 179 (10): 7121-7127.
25. Kotanidou A, Xagorari A, Bagli E, et al., Luteolin reduces lipopolysaccharide-induced lethal toxicity and expression of proinflammatory molecules in mice. Am J Resp Crit Care Med 2002; 165 (6): 818-823.
26. Saw CLL, Wu Q, Su ZY, et al., Effects of natural phytochemicals in Angelica sinensis (Danggui) on Nrf2-mediated gene expression of phase II drug metabolizing enzymes and anti-inflammation. Biopharm Drug Dispos 2013; 34 (6): 303-311.
27. Kang Y-M, Eom S-H, Kim Y-M,. Protective effect of phlorotannins from Eisenia bicyclis against lipopolysaccharide-stimulated inflammation in HepG2 cells. Environ Toxicol Pharmacol 2013; 35 (3): 395-401.
28. Lim JH, Park HS, Choi JK, Lee IS, Choi HJ,. Isoorientin induces Nrf2 pathway-driven antioxidant response through phosphatidylinositol 3-kinase signaling. Arch Pharmacal Res 2007; 30 (12): 1590-1598.
29. Drechsler Y, Dolganiuc A, Norkina O, et al., Heme oxygenase-1 mediates the anti-inflammatory effects of acute alcohol on IL-10 induction involving p38 MAPK activation in monocytes. J Immunol 2006; 177 (4): 2592-2600.
30. Thimmulappa RK, Lee H, Rangasamy T, et al., Nrf2 is a critical regulator of the innate immune response and survival during experimental sepsis. J Clin Invest 2006; 116 (4): 984-995.
31. Weng Z, Patel AB, Vasiadi M, Therianou A, Theoharides TC,. Luteolin inhibits human keratinocyte activation and decreases NF-kappaB induction that is increased in psoriatic skin. PLoS One 2014; 9 (2): e90739.
32. Yun K-J, Kim JY, Kim JB, et al., Inhibition of LPS-induced NO and PGE2 production by asiatic acid via NF-kappa B inactivation in RAW 264.7 macrophages: possible involvement of the IKK and MAPK pathways. Int Immunopharmacol 2008; 8 (3): 431-441.
33. Noroozi M, Angerson WJ, Lean ME,. Effects of flavonoids and vitamin C on oxidative DNA damage to human lymphocytes. Am J Clin Nutr 1998; 67 (6): 1210-1218.
34. Bryan HK, Olayanj A, Goldring CE, Park BK,. The Nrf2 cell defence pathway: Keap1-dependent and -independent mechanisms of regulation. Biochem Pharmacol 2013; 85 (6): 705-717.
35. Sun Z, Huang Z, Zhang DD,. Phosphorylation of Nrf2 at multiple sites by MAP kinases has a limited contribution in modulating the Nrf2-dependent antioxidant response. PLoS One 2009; 4 (8): e6588.
36. Hu R, Saw CL, Yu R, Kong AN,. Regulation of NF-E2-related factor 2 signaling for cancer chemoprevention: antioxidant coupled with antiinflammatory. Antioxid Redox Signal 2010; 13 (11): 1679-1698.
37. Cuadrado A, Martin-Moldes Z, Ye J, Lastres-Becker I,. Transcription factors NRF2 and NF-kappaB are coordinated effectors of the Rho family, GTP-binding protein RAC1 during inflammation. J Biol Chem 2014; 289 (22): 15244-15258.
38. Li W, Khor TO, Xu C, et al., Activation of Nrf2-antioxidant signaling attenuates NFkappaB-inflammatory response and elicits apoptosis. Biochem Pharmacol 2008; 76 (11): 1485-1489.
39. Jeong W-S, Kim IW, Hu R, Kong AN,. Modulatory properties of various natural chemopreventive agents on the activation of NF-kappaB signaling pathway. Pharm Res 2004; 21 (4): 661-670.
40. Gozzelino R, Jeney V, Soares MP,. Mechanisms of cell protection by heme oxygenase-1. Annu Rev Pharmacol Toxicol 2010; 50: 323-354.
41. Lu Y-C, Yeh W-C, Ohashi PS,. LPS/TLR4 signal transduction pathway. Cytokine 2008; 42 (2): 145-151.
42. Covert MW, Leung TH, Gaston JE, Baltimore D,. Achieving stability of lipopolysaccharide-induced NF-kappaB activation. Science 2005; 309 (5742): 1854-1857.
43. Xie QW, Kashiwabara Y, Nathan C,. Role of transcription factor NF-kappa B/Rel in induction of nitric oxide synthase. J Biol Chem 1994; 269 (7): 4705-4708.
44. Surh YJ, Chun KS, Cha HH, et al., Molecular mechanisms underlying chemopreventive activities of anti-inflammatory phytochemicals: down-regulation of COX-2 and iNOS through suppression of NF-kappa B activation. Mutat Res 2001; 480-481: 243-268.
45. Nathan C,. Inducible nitric oxide synthase: what difference does it make? J Clin Invest 1997; 100 (10): 2417-2423.
46. Liang YC, Huang YT, Tsai SH, Lin-Shiau SY, Chen CF, Lin JK,. Suppression of inducible cyclooxygenase and inducible nitric oxide synthase by apigenin and related flavonoids in mouse macrophages. Carcinogenesis 1999; 20 (10): 1945-1952.
47. Park CM, Song Y-S,. Luteolin and luteolin-7-O-glucoside inhibit lipopolysaccharide-induced inflammatory responses through modulation of NF-kappaB/AP-1/PI3K-Akt signaling cascades in RAW 264.7 cells. Nutr Res Pract 2013; 7 (6): 423-429.
48. Khor TO, Huang MT, Prawan A, et al., Increased susceptibility of Nrf2 knockout mice to colitis-associated colorectal cancer. Cancer Prev Res (Phil) 2008; 1 (3): 187-191.
49. Wendum D, Svrcek M, Rigau V, et al., COX-2, inflammatory secreted PLA2, and cytoplasmic PLA2 protein expression in small bowel adenocarcinomas compared with colorectal adenocarcinomas. Mod Pathol 2003; 16 (2): 130-136.
50. Thotala D, Craft JM, Ferraro DJ, et al,. Cytosolic phospholipaseA2 inhibition with PLA-695 radiosensitizes tumors in lung cancer animal models. PLoS One 2013; 8 (7): e69688.